Effect of a Fermented Milk Combining Lactobacillus Acidophilus CL1285 and Lactobacillus Casei in the Prevention of Antibiotic-Associated Diarrhea: A Randomized, Double-Blind, Placebo-Controlled Trial
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Antibiotic-associated diarrhea is an important problem in hospitalized patients. The use of probiotics is gaining interest in the scientific community as a potential measure to prevent this complication. The main objective of the present study was to assess the efficacy and safety of a fermented milk combining Lactobacillus acidophilus and Lactobacillus casei that is widely available in Canada, in the prevention of antibiotic-associated diarrhea. METHODS: In this double-blind, randomized study, hospitalized patients were randomly assigned to receive either a lactobacilli-fermented milk or a placebo on a daily basis. RESULTS: Among 89 randomized patients, antibiotic-associated diarrhea occurred in seven of 44 patients (15.9%) in the lactobacilli group and in 16 of 45 patients (35.6%) in the placebo group (OR 0.34, 95% CI 0.125 to 0.944; P=0.05). The median hospitalization duration was eight days in the lactobacilli group, compared with 10 days in the placebo group (P=0.09). Overall, the lactobacilli-fermented milk was well tolerated. CONCLUSION: The daily administration of a lactobacilli-fermented milk was safe and effective in the prevention of antibiotic-associated diarrhea in hospitalized patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



















Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Five studies examined AAD as a primary end point, with four studies of two different probiotics showing a significant reduction in AAD,40–43 and one underpowered study of another probiotic showing a nonsignificant reduction.45”
From Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide (2013) · cites this paper as [40]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antibiotic-Associated Diarrhea
Bartlett, J. G. (2002) · New England Journal of Medicine · doi:10.1056/nejmcp011603 · Cited by 1,197 · cited 4×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundInfluentialProbiotics: effects on immunity
Isolauri, E., Sütas, Y., Kankaanpää, P., Arvilommi, H., & Salminen, S. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.2.444s · Cited by 1,019 · cited 1×
“for gastrointestinal (GI) colonization and available nutrients, and immunomodulation (7,9-11,13-15).”
BackgroundProbiotics in prevention of antibiotic associated diarrhoea: meta-analysis
D'Souza, A. L., Rajkumar, C., Cooke, J., & Bulpitt, C. J. (2002) · BMJ · doi:10.1136/bmj.324.7350.1361 · Cited by 664 · cited 3×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundMethodPrevention of antibiotic-associated diarrhea by Saccharomyces boulardii: A prospective study
Surawicz, C. M., Elmer, G. W., Speelman, P., McFarland, L. V., Chinn, J., & Van Belle, G. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)91613-2 · Cited by 573
Safety of Probiotics That Contain Lactobacilli or Bifidobacteria
Borriello, S. P., Hammes, W. P., Holzapfel, W., Marteau, P., Schrezenmeir, J., Vaara, M., & Valtonen, V. (2003) · Clinical Infectious Diseases · doi:10.1086/368080 · Cited by 551 · cited 1×
“It is noteworthy that lactobacilli have a long record of safety and have been used for many years in the fermentation process of multiple food products (21,22).”
BackgroundArvola, T., Laiho, K., Torkkeli, S., Mykkänen, H., Salminen, S., Maunula, L., & Isolauri, E. (1999) · Pediatrics · doi:10.1542/peds.104.5.e64 · Cited by 427 · cited 1×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5,6,9-12,15-19).”
BackgroundClostridium difficile-associated diarrhea in adults
Poutanen, S. M. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1031189 · Cited by 410 · cited 3×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundMeta‐analysis: the effect of probiotic administration on antibiotic‐associated diarrhoea
Cremonini, F., Di Caro, S., Nista, E. C., Bartolozzi, F., Capelli, G., Gasbarrini, G., & Gasbarrini, A. (2002) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2002.01318.x · Cited by 384 · cited 3×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5, 6 ,9-12,15-19).”
BackgroundInfluentialPrevention of beta-lactam-associated diarrhea by Saccharomyces boulardii compared with placebo.
McFarland, L. V., Surawicz, C. M., Greenberg, R. N., Elmer, G. W., Moyer, K. A., Melcher, S. A., Bowen, K., & Cox, J. L. (1995) · PubMed · Cited by 383
Probiotic agents and infectious diseases: a modern perspective on a traditional therapy
Alvarez-Olmos, M. I., & Oberhelman, R. A. (2001) · Clinical Infectious Diseases · doi:10.1086/320518 · Cited by 359 · cited 3×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundMechanisms and Management of Antibiotic‐Associated Diarrhea
Hogenauer, C., Hammer, H. F., Krejs, G. J., & Reisinger, E. C. (1998) · Clinical Infectious Diseases · doi:10.1086/514958 · Cited by 348 · cited 4×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundInfluentialProbiotics as Biotherapeutic Agents: Present Knowledge and Future Prospects
Mercenier, A., Pavan, S., & Pot, B. (2003) · Current Pharmaceutical Design · doi:10.2174/1381612033392224 · Cited by 342 · cited 3×
“Because results related to one specific probiotic cannot be extrapolated to another (7), we chose to study a product readily available in Quebec: a fermented milk combining the CL1285 Lactobacillus acidophilus patented strain, and Lactobacillus casei.”
BackgroundEffect of Lactobacillus GG Yoghurt in Prevention of Antibiotic Associated Diarrhoea
Siitonen, S., Vapaatalo, H., Salminen, S., Gordin, A., Saxelin, M., Wikberg, R., & Kirkkola, A.-L. (1990) · Annals of Medicine · doi:10.3109/07853899009147243 · Cited by 326 · cited 3×
“6% [seven of 16 cases] in the placebo group versus 10% to 20%) (1,3-5).”
BackgroundEpidemiology, Risk Factors and Treatments for Antibiotic-Associated Diarrhea
McFarland, L. V. (1998) · Digestive Diseases · doi:10.1159/000016879 · Cited by 310 · cited 1×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundArmuzzi, A., Cremonini, F., Bartolozzi, F., Canducci, F., Candelli, M., Ojetti, V., Cammarota, G., Anti, M., De Lorenzo, A., Pola, P., et al. (2001) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.2001.00923.x · Cited by 296 · cited 3×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5,6,9-12,15-19).”
BackgroundMiller, M. A., Hyland, M., Ofner-Agostini, M., Gourdeau, M., Ishak, M., Canadian Hospital Epidemiology Committee, & Program, C. N. I. S. (2002) · Infection Control & Hospital Epidemiology · doi:10.1086/502023 · Cited by 194 · cited 2×
“The prevention of CDAD is an important outcome to consider, because this condition has been associated with an increased mortality and morbidity (2).”
BackgroundTHOMAS, M. R., LITIN, S. C., OSMON, D. R., CORR, A. P., WEAVER, A. L., & LOHSE, C. M. (2001) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(11)62106-x · Cited by 185 · cited 2×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5,6,9-12,15-19).”
BackgroundProphylaxis against ampicillin-associated diarrhea with a lactobacillus preparation
Gotz, V., Romankiewicz, J. A., Moss, J., & Murray, H. W. (1979) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/36.6.754 · Cited by 177 · cited 1×
“Several studies have investigated the efficacy of prophylactic probiotics in preventing AAD but the heterogeneity of the strains and formulation used limit their external validity (5,6,9-12,15-19).”
BackgroundUse of Probiotics in Childhood Gastrointestinal Disorders
Vanderhoof, J. A., & Young, R. J. (1998) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1998.tb01263.x · Cited by 171 · cited 1×
“It is noteworthy that lactobacilli have a long record of safety and have been used for many years in the fermentation process of multiple food products (21,22).”
BackgroundLewis, S. J., Potts, L. F., & Barry, R. E. (1998) · Journal of Infection · doi:10.1016/s0163-4453(98)80008-x · Cited by 171
Tankanow, R. M., Ross, M. B., Ertel, I. J., Dickinson, D. G., McCormick, L. S., & Garfinkel, J. F. (1990) · DICP · doi:10.1177/106002809002400408 · Cited by 140
Lewis, S. J., & Freedman, A. R. (1998) · Alimentary Pharmacology & Therapeutics · doi:10.1046/j.1365-2036.1998.00386.x · Cited by 121 · cited 1×
“Exclusion criteria included active diarrhea at enrollment, diagnosis of C difficile-associated diarrhea (CDAD) within the previous three months, antibiotic treatment with vancomycin or an aminoglycoside in monotherapy (23), confirmed lactose intolerance, underlying chronic GI tract disease, patients with stomas, use o…”
BackgroundClostridium difficile infection in hospitals: a brewing storm
Valiquette, L., Low, D. E., Pépin, J., & McGeer, A. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040957 · Cited by 55 · cited 1×
“This observation concurs with the 2003 to 2004 fourfold increase in the number of CDAD cases that affected the Montreal area (26,27).”
ResultStoddart, B., & Wilcox, M. H. (2002) · Current Opinion in Infectious Diseases · doi:10.1097/00001432-200210000-00010 · Cited by 48
Hospitals battling outbreaks of C. difficile
Eggertson, L. (2004) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040979 · Cited by 43 · cited 1×
“This observation concurs with the 2003 to 2004 fourfold increase in the number of CDAD cases that affected the Montreal area (26, 27 ).”
Result
Research works printed but not linked: 2
- Surawicz CM, Elmer GW, Speelman P, McFarland LV, Chinn J, van Belle G. Prevention of antibiotic-associated diarrhea by Saccharomyces boulardii. Gastroenterology 1989;96:981-8.
- Adam J, Barret A, Barret-Bellet C. Essais cliniques contrôlés en double insu de l'Ultra-levure lyophilisée: étude multicentrique par 25 médecins de 388 cas. Gaz Med Fr 1977;84:2072-8.
Cited by
Newberry, S. J. (2012) · JAMA · doi:10.1001/jama.2012.3507 · Cited by 870
“68) Safdar,46 2008 4/23 (17) 6/17 (35) 0.”
BackgroundInfluentialProbiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Ma, S. S., Saxton, J. D., Martzen, M. R., Vandvik, P. O., Thorlund, K., Guyatt, G. H., & Johnston, B. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub3 · Cited by 741
McFarland, L. V., Evans, C. T., & Goldstein, E. J. C. (2018) · Frontiers in Medicine · doi:10.3389/fmed.2018.00124 · Cited by 609
Probiotics for the prevention of pediatric antibiotic-associated diarrhea
Goldenberg, J. Z., Lytvyn, L., Steurich, J., Parkin, P., Mahant, S., & Johnston, B. C. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004827.pub4 · Cited by 607
Probiotics for the prevention of Clostridium difficile-associated diarrhea in adults and children
Goldenberg, J. Z., Yap, C., Lytvyn, L., Lo, C. K.-F., Beardsley, J., Mertz, D., & Johnston, B. C. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006095.pub4 · Cited by 550
Metadata
- Authors
- Beausoleil, M., Fortier, N., Guénette, S., L’Ecuyer, A., Savoie, M., Franco, M., Lachaîne, J., & Weiss, K.
- Affiliations
- Hôpital Maisonneuve-Rosemont (CA)
- Université de Montréal (CA)
- Corresponding author
- Beausoleil, Mélanie
- ORCID
- Lachaîne, Jean
- Venue
- Canadian Journal of Gastroenterology
- Publisher
- Hindawi Limited
- Published
- 2007
- Volume
- 21
- Issue
- 11
- Pages
- 732-736
- ISSN
- 0835-7900 (ISSN-L)
- PMC
- PMC2658588
- OpenAlex
- W2147619842
- Cited by
- 162
- References
- 26
- Citations by year
- 2025: 4 · 2024: 4 · 2023: 6 · 2022: 6 · 2021: 11 · 2020: 7 · 2019: 11 · 2018: 9 · 2017: 9 · 2016: 14 · 2015: 15 · 2014: 8 · 2013: 12 · 2012: 11
- FWCI
- 14.11
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Journal of Gastroenterology (publishedVersion, cc-by)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- American College of Gastroenterology
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- antibiotic-associated diarrhea, probiotics, fermented milk, Lactobacillus acidophilus, Lactobacillus casei, hospitalized patients, diarrhea prevention, probiotic safety
- MeSH terms
- Aged, Aged, 80 and over, Animals, Anti-Bacterial Agents, Diarrhea, Double-Blind Method, Female, Fermentation, Humans, Lactobacillus acidophilus, Lacticaseibacillus casei, Length of Stay, Male, Middle Aged, Milk, Odds Ratio, Treatment Outcome, Probiotics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.